Supplier

LFB BIOMEDICAMENTS

LES ULIS · FRA

Track this recordFree account — get alerted when a contract here runs out.

Awards

Total awarded

€1.1bn

2 joint award(s) counted pro rata

Buyers

Sectors

Group: LFB BIOMEDICAMENTS

Reg. 491 371 167 00017

Contracts this supplier holds that are running out

31 Jul 2027
stated
Abschluss eines nicht-exklusiven Rabattvertrages gemäß § 130a Abs. 8 SGB V zwischen der IKK classic und der LFB Biomedicaments zu Willfact und Cevenfacta
IKK classicLFB BIOMEDICAMENTS
€1
30 Apr 2029
stated
J06BA02 - IG HUMAINES POLYVALENTES IV 10% PRETES A L'EMPLOI - STABILISE A LA GLYCINE + POLYSORBATE
GIP RESAHLFB BIOMEDICAMENTS
€356,580
31 May 2029
stated
FACTEUR VIII HUMAIN PLASMATIQUE
Hospices Civils de LyonLFB BIOMEDICAMENTS
€23,849,005
31 May 2029
stated
FACTEUR IX HUMAIN PLASMATIQUE sécurisation virale SD et nanofiltration à 15 nm
Hospices Civils de LyonLFB BIOMEDICAMENTS
€5,178,670
31 May 2029
stated
ALBUMINE HUMAINE 200MG / ML (20%)
Hospices Civils de LyonLFB BIOMEDICAMENTS
€12,956,735
31 May 2029
stated
ALBUMINE HUMAINE 200MG / ML (20%)
Hospices Civils de LyonLFB BIOMEDICAMENTS
€11,501,659
31 May 2029
stated
ALBUMINE HUMAINE 200MG / ML (20%)
Hospices Civils de LyonLFB BIOMEDICAMENTS
€10,859,806
31 May 2029
stated
ALBUMINE HUMAINE 40MG / ML (4%)
Hospices Civils de LyonLFB BIOMEDICAMENTS
€11,484,167
31 May 2029
stated
ALBUMINE HUMAINE 50MG / ML (5%)
Hospices Civils de LyonLFB BIOMEDICAMENTS
€3,380,883
31 May 2029
stated
ALPHA-1 ANTITRYPSINE D'ORIGINE HUMAINE 33.33 MG / ML
Hospices Civils de LyonLFB BIOMEDICAMENTS
€37,930,100
31 May 2029
stated
FIBRINOGENE HUMAIN
Hospices Civils de LyonLFB BIOMEDICAMENTS, OCTAPHARMA FRANCE
€69,652,461
31 May 2029
stated
FACTEUR WILLEBRAND HUMAIN 100 UI / ML PUR
Hospices Civils de LyonLFB BIOMEDICAMENTS
€58,157,024
31 May 2029
stated
FACTEUR XI HUMAIN
Hospices Civils de LyonLFB BIOMEDICAMENTS
€460,257,600
31 May 2029
stated
IG ANTITETANIQUE HUMAIN 250 UI / 2 ML
Hospices Civils de LyonLFB BIOMEDICAMENTS
€2,029,551
31 May 2029
stated
IG SPECIFIQUES ANTI HEPATITE B 100 UI / 1 ML
Hospices Civils de LyonLFB BIOMEDICAMENTS
€2,125,200
31 May 2029
stated
IG SPECIFIQUES ANTI HEPATITE B 500 UI / 5 ML
Hospices Civils de LyonLFB BIOMEDICAMENTS
€1,914,000
31 May 2029
stated
IG SPECIFIQUES ANTI HEPATITE B HUMAINE 5000 UI / 100 ML IV
Hospices Civils de LyonLFB BIOMEDICAMENTS
€14,491,404
31 May 2029
stated
IG POLYVALENTE HUMAINE IV 50MG / ML (5%) PAE - teneur en Ig A < 0.022 mg / ml
Hospices Civils de LyonLFB BIOMEDICAMENTS
€304,767,612
31 May 2029
stated
IG POLYVALENTE HUMAINE IV 50 MG/ML (5%) LYOPHILISE
Hospices Civils de LyonLFB BIOMEDICAMENTS
€56,145,276

All expiring contracts →

Awards

Awarded	Buyer	Winner	Contract value	Published
J06BA02 - IG HUMAINES POLYVALENTES IV 10% PRETES A L'EMPLOI - STABILISE A LA GLYCINE + POLYSORBATE	GIP RESAH	LFB BIOMEDICAMENTS	€356,580	3 Apr 2026
Abschluss eines nicht-exklusiven Rabattvertrages gemäß § 130a Abs. 8 SGB V zwischen der IKK classic und der LFB Biomedicaments zu Willfact und Cevenfacta	IKK classic	LFB BIOMEDICAMENTS	€1	22 Aug 2025
PROTEINE C HUMAIN	CHU ROUEN NORMANDIE	LFB BIOMEDICAMENTS, TAKEDA FRANCE SAS	€21,420,000	19 Aug 2025
Fourniture de spécialités pharmaceutiques au profit des adhérents du GCS GRAPS Grand Est lots 207,248,253,258,262,267,271,276,295,910,911,918,919,921	GCS GRAPS Grand Est	LFB BIOMEDICAMENTS	€37,162,178	15 May 2025
IG POLYVALENTE HUMAINE IV 50 MG/ML (5%) LYOPHILISE	Hospices Civils de Lyon	LFB BIOMEDICAMENTS	€56,145,276	29 Apr 2025
IG POLYVALENTE HUMAINE IV 50MG / ML (5%) PAE - teneur en Ig A < 0.022 mg / ml	Hospices Civils de Lyon	LFB BIOMEDICAMENTS	€304,767,612	29 Apr 2025
IG SPECIFIQUES ANTI HEPATITE B HUMAINE 5000 UI / 100 ML IV	Hospices Civils de Lyon	LFB BIOMEDICAMENTS	€14,491,404	29 Apr 2025
IG SPECIFIQUES ANTI HEPATITE B 500 UI / 5 ML	Hospices Civils de Lyon	LFB BIOMEDICAMENTS	€1,914,000	29 Apr 2025
IG SPECIFIQUES ANTI HEPATITE B 100 UI / 1 ML	Hospices Civils de Lyon	LFB BIOMEDICAMENTS	€2,125,200	29 Apr 2025
IG ANTITETANIQUE HUMAIN 250 UI / 2 ML	Hospices Civils de Lyon	LFB BIOMEDICAMENTS	€2,029,551	29 Apr 2025
FACTEUR XI HUMAIN	Hospices Civils de Lyon	LFB BIOMEDICAMENTS	€460,257,600	29 Apr 2025
FACTEUR WILLEBRAND HUMAIN 100 UI / ML PUR	Hospices Civils de Lyon	LFB BIOMEDICAMENTS	€58,157,024	29 Apr 2025
FIBRINOGENE HUMAIN	Hospices Civils de Lyon	LFB BIOMEDICAMENTS, OCTAPHARMA FRANCE	€69,652,461	29 Apr 2025
ALPHA-1 ANTITRYPSINE D'ORIGINE HUMAINE 33.33 MG / ML	Hospices Civils de Lyon	LFB BIOMEDICAMENTS	€37,930,100	29 Apr 2025
ALBUMINE HUMAINE 50MG / ML (5%)	Hospices Civils de Lyon	LFB BIOMEDICAMENTS	€3,380,883	29 Apr 2025
ALBUMINE HUMAINE 40MG / ML (4%)	Hospices Civils de Lyon	LFB BIOMEDICAMENTS	€11,484,167	29 Apr 2025
ALBUMINE HUMAINE 200MG / ML (20%)	Hospices Civils de Lyon	LFB BIOMEDICAMENTS	€10,859,806	29 Apr 2025
ALBUMINE HUMAINE 200MG / ML (20%)	Hospices Civils de Lyon	LFB BIOMEDICAMENTS	€11,501,659	29 Apr 2025
ALBUMINE HUMAINE 200MG / ML (20%)	Hospices Civils de Lyon	LFB BIOMEDICAMENTS	€12,956,735	29 Apr 2025
FACTEUR IX HUMAIN PLASMATIQUE sécurisation virale SD et nanofiltration à 15 nm	Hospices Civils de Lyon	LFB BIOMEDICAMENTS	€5,178,670	29 Apr 2025
FACTEUR VIII HUMAIN PLASMATIQUE	Hospices Civils de Lyon	LFB BIOMEDICAMENTS	€23,849,005	29 Apr 2025
IG POLYVALENTE HUMAINE IV 50MG / ML (5%) PAE - teneur en Ig A < 0.022 mg / ml	CH de Saint-Brieuc/Paimpol/Tréguier - Etablissement support du GHT d'ARMOR	LFB BIOMEDICAMENTS	€1,033,560	24 Apr 2025
IG POLYVALENTE HUMAINE IV 50 MG/ML (5%) LYOPHILISE - Indication poussées aigues de myasthénie et retinochoroïde de birshot	CH de Saint-Brieuc/Paimpol/Tréguier - Etablissement support du GHT d'ARMOR	LFB BIOMEDICAMENTS	€120,713	24 Apr 2025